Results
Venmax Drugs Q2 FY27 Revenue Surges 300% YoY
Venmax Drugs reported unaudited Q2 FY27 standalone results with revenue surging to ₹528.21 lakhs, a 300% YoY increase.
Net profit for the quarter stood at ₹12.03 lakhs, significantly higher than ₹2.44
